Adaptive immune responses during acute uncomplicated and fulminant hepatitis E

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 2, 2011, Pages 306-311

  Srivastava, Ratika ^a   Aggarwal, Rakesh ^a   Sachdeva, Sanjeev ^a   Alam, Mohammad Intakhab ^b   Jameel, Shahid ^b   Naik, Sita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Hepatitis E virus; Hepeviridae; Liver injury; Pathogenesis

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADAPTIVE IMMUNITY; ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL;

EID: 78851471576     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06356.x     Document Type: Article

References (25)

1. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 2009; 24: 1484-93.
2. Chandra V, Taneja S, Kalia M, Jameel S. Molecular biology and pathogenesis of hepatitis E virus. J. Biosci. 2008; 33: 451-64.
3. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005; 5: 215-29.
4. Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J. Viral Hepat. 2008; 15: 910-16.
5. Aggarwal R, Shukla R, Jameel S etal. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J. Viral Hepat. 2007; 14: 283-92.
6. Srivastava R, Aggarwal R, Jameel S etal. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol. 2007; 20: 56-65.
7. Trey C, Davidson C. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Disease, vol. 3. New York: Grune and Stratton, 1970; 282-98.
8. Zafrullah M, Khursheed Z, Yadav S, Sahgal D, Jameel S, Ahmad F. Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus. Biochem. Biophys. Res. Commun. 2004; 313: 67-73.
9. Panda SK, Nanda SK, Zafrullah M, Ansari IH, Ozdener MH, Jameel S. An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J. Clin. Microbiol. 1995; 33: 2653-59.
10. Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 2006; 1: 23-61.
11. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001; 194: 1395-406.
12. Tsai SL, Huang SN. T cell mechanisms in the immunopathogenesis of viral hepatitis B and C. J. Gastroenterol. Hepatol. 1997; 12: S227-35.
13. Urbani S, Amadei B, Fisicaro P etal. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006; 44: 126-39.
14. Kamar N, Selves J, Mansuy JM etal. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008; 358: 811-17.
15. Haagsma EB, van den Berg AP, Porte RJ etal. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008; 14: 547-53.
16. Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S. Immunological alterations in pregnant women with acute hepatitis E. J. Gastroenterol. Hepatol. 2005; 20: 1094-101.
17. Kar P, Jilani N, Husain SA etal. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am. J. Gastroenterol. 2008; 103: 2495-501.
18. Bruccoleri A, Gallucci R, Germolec DR etal. Induction of early-immediate genes by tumor necrosis factor contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 1997; 25: 133-41.
19. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 1997; 94: 1441-46.
20. Prusty BK, Hedau S, Singh A, Kar P, Das BC. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol. Med. 2007; 13: 518-26.
21. Reuman PD, Bernstein DI, Keely SP, Sherwood JR, Young EC, Schiff GM. Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition. Antiviral Res. 1990; 13: 103-10.
22. Lee N, Chan PK, Ip M etal. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. J. Clin. Virol. 2006; 35: 179-84.
23. Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J. Gen. Virol. 2007; 88: 365-75.
24. Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ. Immunoglobulin G antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J. Virol. 2006; 80: 8530-40.
25. Nylander S, Kalies I. Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry. J. Immunol. Methods 1999; 224: 69-76.